UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

~~SECURITIES~~Form ~~AND EXCHANGE COMMISSION~~6-K

~~Washington,~~REPORT ~~D.C.~~OF ~~20549~~FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File ~~No.~~ Number: 001-42024

~~MINGTENG~~Mingteng ~~INTERNATIONAL~~International ~~CORPORATION~~Corporation ~~INC~~Inc.

(Translation of registrant’s name into English)

No. 10 Fushi Road, Luoshe Town, Huishan District,

Wuxi, Jiangsu Province, China 214000 (Address of principal executive office)

~~(Address~~Indicate by check mark whether the registrant files or will file annual reports under cover of ~~principal~~Form ~~executive~~20-F ~~office)~~or Form 40-F.

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒ Form 40-F ☐

~~Entry~~Extraordinary ~~into~~General aMeeting ~~Material~~of ~~Definitive Agreement.~~Shareholders

On December 415, 2025, ~~Mingteng~~at ~~International Corporation~~10:00 ~~Inc~~A.M., China Standard Time (~~the~~December ~~“Company”)~~14, a2025, ~~company~~at ~~incorporated~~9:00 inP.M., ~~Cayman~~Eastern ~~Islands~~Time), ~~entered~~Mingteng ~~into~~International anCorporation ~~at-the-market~~Inc. ~~sales agreement~~ (the “~~Sales Agreement~~Company”) held ~~with~~an ACextraordinary ~~Sunshine~~general ~~Securities~~meeting ~~LLC,~~of asshareholders ~~sales agent~~ (the “~~Agent~~Meeting”), ~~pursuant~~at toNo. ~~which~~10 ~~the~~Fushi ~~Company~~Road, ~~may~~Luoshe ~~offer~~Town, ~~and~~Huishan District, ~~sell~~Wuxi, ~~from~~Jiangsu ~~time~~Province, toChina ~~time~~214000. ~~through~~Holders ~~the~~of ~~Agent~~2,658,023 Class A ordinary shares, ~~par~~and ~~value~~2,091,000 ~~$0.00001 per share (the “~~Class AB ~~Ordinary~~ordinary ~~Shares”),~~ shares of the Company were ~~(the~~present ~~Class~~in Aperson ~~Ordinary~~or ~~Shares~~by toproxy beat ~~sold pursuant to~~ the ~~Sales Agreement~~Meeting, ~~the~~representing ~~“Shares”)~~approximately 95.47% ~~The offer and sale~~ of the ~~Shares,~~total ifvoting ~~any,~~rights ~~will~~of beall ~~made~~of ~~pursuant to~~ the ~~Company’s~~issued ~~shelf~~ordinary shares ~~registration~~of ~~statement on Form F-3 (File No. 333-287843), including~~ the ~~base~~Company ~~prospectus~~as ~~contained~~of ~~therein, which was initially filed with~~ the ~~United~~record ~~States~~date ~~Securities~~of ~~and~~November ~~Exchange Commission (the “Commission”) on June 6~~13, 2025, and ~~was~~therefore ~~declared~~constituting ~~effective,~~a asquorum ~~amended,~~of by the ~~Commission~~ordinary onshares ~~November~~outstanding and ~~18,~~entitled ~~2025~~to ~~and~~vote asat ~~supplemented~~the byEGM as of the ~~prospectus supplement,~~record ~~dated~~date. ~~December~~All 8,matters ~~2025,~~voted ~~filed~~on ~~with~~at the ~~Commission~~Meeting ~~pursuant~~were toapproved ~~Rule~~as ~~424(b)(4)~~recommended ofby the ~~Securities~~Board ~~Act~~of Directors of ~~1933,~~the asCompany ~~amended~~and ~~(the “Securities~~were ~~Act”),~~approved ~~relating~~at to the ~~Shares~~Meeting. ~~which~~The ~~may~~final bevoting ~~issued~~results ~~from~~for ~~time~~each tomatter ~~time~~submitted ~~pursuant~~ to ~~the~~a ~~Sales~~vote ~~Agreement,~~of ~~(the “Prospectus~~shareholders ~~Supplement”).~~at ~~Pursuant to~~ the ~~Prospectus~~Meeting ~~Supplement,~~are ~~the~~as ~~Company may offer and sell up to U.S.$100,000,000 of Shares.~~follows:

Under the Sales Agreement, subject to the terms of the placement notice defined in the Sales Agreement, the Agent may sell Placement Shares by any method permitted by law deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act, including, without limitation, sales made directly on the Exchange, on any other existing trading market for the Ordinary Shares or to or through a market maker.

		For	Against	Abstain
Proposal One:	By an ordinary resolution, (A) to approve one or more share consolidations of the Company’s issued and unissued Class A ordinary shares of par value of US$0.00001 each (the “Class A Ordinary Shares”) and Class B ordinary shares of par value of US$0.00001 each (the “Class B Ordinary Shares”) at a ratio of not less than two (2)-for-one (1) and not more than four-thousand (4,000)-for-one (1) or the maximum consolidation ratio then permitted under applicable Nasdaq rules and requirements aggregately (the “Range”), with the exact ratio to be set at a whole number within the Range and the exact date to be determined by the Board in its sole discretion within two years after the date of passing of these resolutions (each a “Share Consolidation” and collectively, the “Share Consolidations”) provided that the aggregate ratio shall not exceed four-thousand (4,000)-for-one (1) or such lower cap as imposed by Nasdaq at the time of implementation and that no fractional share shall arise from the Share Consolidations, (B) to authorize the Company to round up any fractional shares resulting from the Share Consolidations to the nearest whole Class A Ordinary Share or and Class B Ordinary Share, and (C) to authorize the Board to, its sole and absolute discretion, implement one or more Share Consolidations, determine the exact consolidation ratio and the exact effective date of such Share Consolidation, instruct the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidations and do all other such acts and things as the Board considers necessary or desirable for the purposes of the transactions contemplated by the Share Consolidation(s).	44,431,925	46,098	0

Proposal Two:	By a special resolution to approve, subject to and conditional upon the effectiveness of a Share Consolidation as approved under Proposal One: (i) to amend and restate the currently effective memorandum and articles of association of the Company by their deletion in their entirety and the substitution in their place with an amended and restated memorandum and articles of association (the “Third ARMA”) to reflect the Share Consolidation effected pursuant to Proposal One; (ii) to authorize the Board that, upon the determination of the final consolidation ratio by the Board within the Range approved in Proposal One, to make such amendments to the share capital clause of the then effective memorandum and articles of association of the Company, to reflect such Share Consolidation upon its relevant effective date as and when determined by the Board; and (iii) to authorize the Company’s registered office provider or other duly authorized representative to file these resolutions, the Board resolutions in relation to such Share Consolidation and the Third ARMA with the Registrar of Companies in the Cayman Islands accordingly and authorize the Board to take all further actions and execute all further documents as may be necessary or advisable to carry out the intent of these resolutions.	43,839,781	14,612	140

Proposal Three:	By an ordinary resolution, to adjourn the Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal One and Two.	44,431,758	46,122	143

The Company is not obligated to make any sales of Shares under the Sales Agreement and no assurance can be given that it will sell any Shares under the Sales Agreement, or, if it does, as to the price or number of Shares that it will sell, or the dates on which any such sales will take place. The aggregate compensation payable to the Agent as sales agent is equal to 3.5% of the aggregate gross proceeds from each Placement Shares sold pursuant to the Sales Agreement. The Company has also agreed to reimburse the Agent for expenses in connection with entering into the Sales Agreement.

The Sales Agreement may be terminated by either party as set forth in the Sales Agreement. Unless earlier terminated by the Agent or the Company, the Sales Agreement shall automatically terminate upon the earlier to occur of (i) issuance and sale of all of the Shares to or through the Agent on the terms and subject to the conditions set forth in the Sales Agreement; (ii) the expiration of the Registration Statement on the third (3rd) anniversary of the initial effective date of the Registration Statement pursuant to Rule 415(a)(5) under the Securities Act; and (iii) November 21, 2026.

In addition, the Company has agreed in the Sales Agreement to provide indemnification and contribution to the Agent against certain liabilities, including liabilities under the Securities Act. The Sales Agreement also contains customary representations and warranties and conditions to the sale of the Shares pursuant thereto.

The foregoing is not a complete description of the Sales Agreement and is qualified by reference to the full text and terms of the Sales Agreement, which is filed as Exhibit 10.1 to this current report and incorporated herein by reference.

The Company plans to use the net proceeds from this offering for general corporate purposes, including business diversification and development initiatives, and capital expenditures.

General

The information contained in this Report on Form 6-K of the Company, are hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-287843) and Registration Statement on Form S-8 (File No. 333-283203).

This Report on Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy the Shares discussed herein, nor shall there be any offer, solicitation, or sale of securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Exhibit Index

Exhibit No.
5.1		Opinion of Mourant Ozannes (Cayman) LLP
10.1		Sales Agreement, dated December 4, 2025 by and between Mingteng International Corporation Inc. and AC Sunshine Securities LLC
23.1		Consent of Mourant Ozannes (Cayman) LLP (included in Exhibit 5.1)

~~SIGNATURE~~SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, ~~hereunto~~thereunto duly authorized.

	Mingteng International Corporation Inc.
Date: December 8, 2025	By:	/s/ Yingkai Xu
	Name:	Yingkai Xu
	Title:	CEO

Date: December 18, 2025

Mingteng International Corporation Inc.

	By:	/s/ Yingkai Xu
	Name:	Yingkai Xu
	Title:	Chief Executive Officer

Filing Compare · Mingteng International Corp Inc.